Sygnature Discovery receives Crédit d’Impôt Recherche accreditation

Sygnature Discovery, is delighted to announce the attainment of the Crédit d’Impôt Recherche (CIR) accreditation, granted by the prestigious French Ministère de l’Éducation nationale, de l’Enseignement supérieur et de la Recherche. This significant milestone allows French companies to take advantage of substantial tax relief on drug discovery research endeavors conducted by Sygnature on their behalf.

This accreditation, bestowed upon Sygnature Discovery, offers a host of benefits to French enterprises engaged in research and development. Through the CIR program, eligible companies can now leverage tax incentives and deductions, fostering an environment conducive to advancing scientific breakthroughs.

For more information about the CIR accreditation and its impact on drug discovery research in France, please visit http://www.education.gouv.fr/

 

Latest News

View All

First patients dosed in Phase 1a clinical…

Sygnature Discovery Appoints Industry Leaders To Board…

Sygnature Discovery invests £3.75M in Compound Management…

Sygnature Discovery collaborates with Axol Bioscience to…